THANK YOU HAVE VISITED THIS WEB
Showing posts with label suspensions in pharmaceutical formulations. Show all posts
Showing posts with label suspensions in pharmaceutical formulations. Show all posts

Pouchers Perfumes Cosmetics And Soaps 10th Edition




Table of sContributors. Preface. Foreword. Part 1: Historical Background. 1. W.A. Poucher's Influence on the Early 20th Century Cosmetic Industry; H. Butler. 2. Cosmetics through the Ages; H. Butler. Part 2: Cosmetics For Everyday Use. 3. Antiperspirants and Deodorants; P. Klepak, J. Walkey. 4. Bath and Shower Products; A.L.L. Hunting. 5. Colouring Materials Used in Decorative Cosmetics and Colour Matching; P. Riley. 6. Decorative Cosmetics; P. Riley. 7. Dental Hygiene; S. Mason, S. Hodgetts. 8. Hair Treatments; F.J. Mottram, C.E. Lees. 9. Hair Shampoos; F.J. Mottram, C.E. Lees. 10. Haircolourants; B.P. Murphy. 11. Manicure Preparations; M.L. Schlossman. 12. Men's Toiletries; P. Paniccia. 13. Pressurized Dispensers; J. McAllister. 14. Skin Preparations; G. Abamba. 15. Soap; M.J. Willcox. 16. Sun Damage and Sunscreen Preparations; M. Brown, N. Fardell. Part 3: Stability and Safety. 17. Analytical Methods; K. Spears. 18. Efficacy Testing of Cosmetics and Toiletries; M. Roberts. 19. Emulsion Theory; J.L. Knowlton. 20. Legislation and Safety Regulations for Cosmetics in the United States, the European Union and Japan; P.D. Wilkes. 21. Microbiological Control of Cosmetics; H. Butler. 22. Safety; J.D. Middleton. 23. Stability; J.S. Cannell. Part 4: Perfumes: Their Manufacture in Products and Psychology in Use. 24. Perfume and the Manufacture of Consumer Products; N.J. Van Abbé. 25. The Psychology of Fragrance and


This Ebook Can be Download:

Global Pharmaceutical Marketing: A Practical Guide to Codes and Compliance



Worldwide, there are varying Codes of Practice/Conduct for the pharmaceutical industry that ensure the industry self-regulates to promote the appropriate use of medicines by operating in a professional, ethical and transparent manner and ensuring high standards.The aim of this book is to aid the understanding of the many pharmaceutical Codes of Practice/Conduct throughout the world. It contains an overview of the guidelines for the promotion of pharmaceutical products in all geographical areas.Each section includes a "general overview" providing a discussion on that particular Code of Practice and differences/similarities with other countries.

This Ebook Can be Download at:

Handbook of Cosmetic Science and Technology, Third Edition

Ebook introduction of knowledge about the technology in the manufacture of cosmetics and testing physical properties of the chemical in the manufacture of dosage formulations of cosmetics are increasingly made ​​by pharmaceutical companies.
for more details, please be listened to with a good ebook that has been provided here.







This Ebook Can be Download at :

Encyclopedia of Clinical Pharmacy


This reference presents the latest procedures, practice guidelines, consensus documents, technological strategies, and regulatory standards for optimal pharmaceutical care–offering summaries for practical applications in a variety of clinical settings, including community and health-system pharmacies, clinics, hospice and long-term care facilities, government agencies, and pharmaceutical research and development organizations.






This ebook can be download at:


ACARBOSE




TRADE NAME

Glucobay, Eclid, Precose

-

DOSE

These drugs are generally administered with a starting dose of 50 mg and increased gradually to 150-600 mg / day. It is advisable to consume it with a full glass of water on the first bribes breakfast / dining

-

INDICATIONS

In addition to sulfonylurea or biguanida Oho therapy in diabetes mellitus which can not be controlled with diet and drug-drug. Acarbose is particularly beneficial for patients with DM tended to increase blood sugar immediately after eating (postprandial hyperglycemia), diabetic patients treated with insulin, will generally decrease the use of insulin if it is combined with acarbose.Obat-alpha-glucosidase inhibitor drugs can be administered as a drug alone or in combination with other diabetes drugs, such as class Oho sulfonylurea, metformin, or insulin .-

CONTRAINDICATIONS

Hypersensitivity to acarbose
Diabetic ketoacidosis
Bowel obstruction, partial or whole
Inflammation or sores / ulcers of the colon
Hemorrhoids
Other chronic bowel disease or other diseases that will worsen in the event of excessive gas formation in the gastrointestinal tract.
-

SIDE EFFECTS

Acarbose is not absorbed into the blood, therefore adverse systemic side minimal.Efek oft happens, especially with stomach disorders, more gas, more frequent flatulence and sometimes diarrhea, which will be reduced after the treatment lasts longer. Side effects can be reduced with reducing consumption karbohidrat.Kadang times can occur itching and red spots on the skin, shortness of breath, throat felt clogged, swelling of the lips, tongue or wajah.Bila taken together drugs known as sulfonylureas or with insulin, hypoglycemia can occur which can only be solved with pure glucose, so it can not be overcome by giving sucrose (sugar).

-

DRUG INTERACTION

With Other Drugs:

Alcohol: may increase hypoglycemic effects. Digestive enzyme supplements such as pancreatin (amylase, protease, lipase) can reduce the effects of acarbose when consumed simultaneously. Calcium antagonists: eg nifedipine sometimes interfere with glucose tolerance. Hormone antagonists: aminoglutetimid can speed up metabolism Oho; oktreotid can lower insulin requirements and Oho.Antihypertensive diazoksid: against hypoglycemic effect. Antidepressants (MAO inhibitors) improve the hypoglycemic effect. Steroid hormones: estrogen and progesterone (oral contraceptives) antagonist effects of hypoglycemia. Klofibrat: may improve glucose tolerance and has an additive effect on Oho. Beta adrenoreceptor blockers: increased hypoglycemic effects and cover the warning symptoms such as tremors. ACE inhibitors: may increase hypoglycemic effects.Ion exchange resins: cholestyramine enhance hypoglycemic effects of acarbose.Drugs that can affect blood glucose levels, such as diuretic drugs (eg hidroklortiazida, klorotiazida, klortalidon, indapamid, etc.), steroidal compounds (eg, prednisone, methylprednisolone, estrogen), compounds phenothiazines (eg chlorpromazine, prochlorperazine, promethazine), hormone-thyroid hormone, phenytoin, calcium channel blockers (eg verapamil, diltiazem, nifedipine).

Foods: none

-

WORKING MECHANISM

Inhibit the enzyme alpha-glucosidase is located on the wall of the small intestine and inhibits the enzyme alpha-amylase of the pancreas, so the overall inhibiting digestion and absorption of carbohydrates. Acarbose does not stimulate insulin secretion by ß-cells of Langerhans pancreas gland.

The compounds alpha-glucosidase inhibitors inhibit the enzyme alpha-glucosidase located in the intestinal wall. The enzymes alpha glucosidase (maltase, isomaltase, glukomaltase and sukrase) serves to hydrolyze oligosaccharides, on the intestinal wall work halus.Inhibisi this enzyme can effectively reduce the digestion of complex carbohydrates and absorbsinya, so it can reduce post-prandial increase in glucose levels in diabetic patients. The compound alpha-glucosidase inhibitors also inhibit pancreatic enzyme a-amylase which hydrolyzes polysaccharides work in the small intestine lumen. Acarbose does not stimulate insulin secretion by ß-cells of Langerhans pankreas.Oleh gland because it does not cause hypoglycemia, unless administered together with another or with Oho insulin.Obat is effective for patients with high-carbohydrate diet and fasting plasma glucose levels less of 180 mg / dl.Pasien who received acarbose therapy alone generally will not increase weight, even slightly menurun.Acarbose will be administered in combination therapy with sulfonylurea, metformin, or insulin.

-

SPECIMENS

Tablets 25 mg, 50 mg, and 100 mg


Storage Stability

Do not store above 25 ° C. Keep away from moisture, should always be tightly closed container.

-

MONITORING PARAMETERS

Fasting blood glucose levels: 80-120mg/dl
Hemoglobin A1c: <100mg/dl
Symptoms of hypoglycemia
-

PATIENT INFORMATION

Do not consume other drugs without a doctor's permission.
This drug is only acting as the controlling diabetes, not a healer.
These drugs are only contributing factor in the management of diabetes, the main factor is the control diet (diet) and exercise.
Consumption of drugs according to dose and use the rules of the doctor
Monitor blood glucose levels as recommended by the doctor
If you experience symptoms of hypoglycemia (dizziness, weakness, trembling, dazed look), apoplexy (view becomes dark), cold sweat, heart rate increases, immediately call your doctor.
If you've ever experienced hypoglycemia, always carry a small bag of sugar if you are traveling. Immediately eating sugar so you get an attack of hypoglycemia.
Report to your doctor if you are planning to become pregnant
This drug should not be consumed during pregnancy or breastfeeding, unless permitted by the physician.

STRUCTURE OF COMPOUND

Pharmaceutical Suspensions

https://encrypted.google.com/books?id=nQzpjIg_TfUC&printsec=frontcover&img=1&zoom=1&source=gbs_apiThe suspension dosage form has long been used for poorly soluble active ingredients for various therapeutic indications. Development of stable suspensions over the shelf life of the drug product continues to be a challenge on many fronts. A good understanding of the fundamentals of disperse systems is essential in the development of a suitable pharmaceutical suspension. The development of a suspension dosage form follows a very complicated path. The selection of the proper excipients (surfactants, viscosity imparting agents etc.) is important. The particle size distribution in the finished drug product dosage form is a critical parameter that significantly impacts the bioavailability and pharmacokinetics of the product. Appropriate analytical methodologies and instruments (chromatographs, viscometers, particle size analyzers, etc.) must be utilized to properly characterize the suspension formulation. The development process continues with a successful scale-up of the manufacturing process. Regulatory agencies around the world require clinical trials to establish the safety and efficacy of the drug product. All of this development work should culminate into a regulatory filing in accordance with the regulatory guidelines. Pharmaceutical Suspensions, From Formulation Development to Manufacturing, in its organization, follows the development approach used widely in the pharmaceutical industry. The primary focus of this book is on the classical disperse system – poorly soluble active pharmaceutical ingredients suspended in a suitable vehicle. After discussing various disperse systems, the theory of disperse systems and commonly used excipients, the remaining chapters in this textbook systematically explain the development of pharmaceutical suspensions, from the pre-formulation stage to clinical development, regulatory submission and commercial manufacturing. Additionally, the emerging area of nano-suspensions as applied to the pharmaceutical field is also discussed. Each of the chapters in Pharmaceutical Suspensions was written independently by scientists who are skilled in their specific areas. Contributing authors represent a cross-sections of scholars from academic, industrial and governmental affiliations. Pharmaceutical Suspensions, From Formulation Development to Manufacturing is organized in a total of ten chapters: Chapter 1 introduces various pharmaceutical disperse systems in-depth. Chapter 2 presents the general principles of suspension dosage form and Chapter 3 discusses commonly used excipients in pharmaceuticalvi Preface suspensions. Chapter 4 systematically highlights steps involved in pharmaceutical development of suspension dosage forms. Chapter 5 focuses on preclinical development of suspension formulations. Analytical tools needed to characterize pharmaceutical suspensions dosage forms are discussed in Chapter 6. The clinical development aspects of suspension drug products are discussed in Chapter 7. Chapter 8 highlights scale up and technology transfer of the development of pharmaceutical suspensions. Chapter 9 reviews the science and regulatory perspectives of pharmaceutical suspensions. Finally, Chapter 10 deals with the pharmaceutical applications of nano-suspensions as nanomedicine, an emerging technology area. Pharmaceutical Suspensions, From Formulation Development to Manufacturing should serve as a good resource for pharmaceutical scientists, process scientists and chemical engineers involved in the areas of research and development of pharmaceutical suspension dosage forms, and for new and sustaining scientists of the pharmaceutical and chemical fields. The fundamental aspects together with the practical case studies should also make this a useful source for undergraduate and

graduate education.Forth Worth, TX Alok K. Kulshreshtha, Ph.D.
Onkar N. Singh. Ph.D., M.B.A.
G. Michael Wall, Ph.D.


This ebook can be download at:


Related Posts Plugin for WordPress, Blogger...
THANK YOU HAVE VISITED THIS WEB